Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles

Background— Repair of the endothelium after vascular injury is crucial for preserving endothelial integrity and preventing the development of vascular disease. The underlying mechanisms of endothelial cell repair are largely unknown. We sought to investigate whether endothelial microparticles (EMPs), released from apoptotic endothelial cells (ECs), influence EC repair. Methods and Results— Systemic treatment of mice with EMPs after electric denudation of the endothelium accelerated reendothelialization in vivo. In vitro experiments revealed that EMP uptake in ECs promotes EC migration and proliferation, both critical steps in endothelial repair. To dissect the underlying mechanisms, Taqman microRNA array was performed, and microRNA (miR)-126 was identified as the predominantly expressed miR in EMPs. The following experiments demonstrated that miR-126 was transported into recipient human coronary artery endothelial cells by EMPs and functionally regulated the target protein sprouty-related, EVH1 domain-containing protein 1 (SPRED1). Knockdown of miR-126 in EMPs abrogated EMP-mediated effects on human coronary artery endothelial cell migration and proliferation in vitro and reendothelialization in vivo. Interestingly, after simulating diabetic conditions, EMPs derived from glucose-treated ECs contained significantly lower amounts of miR-126 and showed reduced endothelial repair capacity in vitro and in vivo. Finally, expression analysis of miR-126 in circulating microparticles from 176 patients with stable coronary artery disease with and without diabetes mellitus revealed a significantly reduced miR-126 expression in circulating microparticles from diabetic patients. Conclusions— Endothelial microparticles promote vascular endothelial repair by delivering functional miR-126 into recipient cells. In pathological hyperglycemic conditions, EMP-mediated miR-126–induced EC repair is altered.

[1]  Shunsuke Noguchi,et al.  Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[3]  Stefanie Dimmeler,et al.  Circulating MicroRNAs in Patients With Coronary Artery Disease , 2010, Circulation research.

[4]  M. Hristov,et al.  Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.

[5]  A. Zeiher,et al.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? , 2004, Journal of Molecular Medicine.

[6]  V. Paradis,et al.  Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. , 2012, Gastroenterology.

[7]  Joshua T. Mendell,et al.  MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.

[8]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[9]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[10]  Jean Tichet,et al.  Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia , 2009, Nature Genetics.

[11]  T. V. van Berkel,et al.  Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. , 2005, Blood.

[12]  A. Yoshimura,et al.  The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization , 2004, Oncogene.

[13]  A. Tedgui,et al.  Microparticles and type 2 diabetes. , 2008, Diabetes & metabolism.

[14]  P. Libby Changing concepts of atherogenesis , 2000, Journal of internal medicine.

[15]  C. Coch,et al.  Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function , 2011, Circulation research.

[16]  Françoise Dignat-George,et al.  The Many Faces of Endothelial Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Tomohiro Sakamoto,et al.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. , 2005, Journal of the American College of Cardiology.

[18]  G. Sesti,et al.  Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells , 2002, Circulation.

[19]  S. King,et al.  Revascularization for coronary artery disease: stents versus bypass surgery. , 2010, Annual review of medicine.

[20]  G. Nickenig,et al.  Microparticles – messengers of biological information , 2010, Journal of cellular and molecular medicine.

[21]  Microparticles, Vascular Function, and Atherothrombosis , 2011, Circulation research.

[22]  S. Fichtlscherer,et al.  Transcoronary Concentration Gradients of Circulating MicroRNAs , 2011, Circulation.

[23]  Swapan K Dasgupta,et al.  Lactadherin and clearance of platelet-derived microvesicles. , 2008, Blood.

[24]  G. Camussi,et al.  Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. , 2012, Kidney international.

[25]  E. Falk,et al.  Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. , 2012, Cardiovascular research.

[26]  Ariel Roguin,et al.  Involvement of microparticles in diabetic vascular complications , 2011, Thrombosis and Haemostasis.

[27]  K. Strebhardt,et al.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy , 2010, Nature Reviews Drug Discovery.

[28]  E. Latz,et al.  Endothelial Microparticle Uptake in Target Cells Is Annexin I/Phosphatidylserine Receptor Dependent and Prevents Apoptosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[29]  G. Pierce,et al.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression. , 2011, Experimental and clinical cardiology.

[30]  V. Paradis,et al.  Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice. , 2012, Radiology.

[31]  Kevin Croce,et al.  Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. , 2011, JACC. Cardiovascular interventions.

[32]  T. Chavakis,et al.  Developmental Endothelial Locus-1 (Del-1) Mediates Clearance of Platelet Microparticles by the Endothelium , 2012, Circulation.

[33]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[34]  Chantal M Boulanger,et al.  Microparticles From Human Atherosclerotic Plaques Promote Endothelial ICAM-1–Dependent Monocyte Adhesion and Transendothelial Migration , 2011, Circulation research.

[35]  Achilleas S. Frangakis,et al.  Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.

[36]  E. Falk,et al.  Circulating Endothelial Progenitor Cells Do Not Contribute to Plaque Endothelium in Murine Atherosclerosis , 2010, Circulation.

[37]  Mark Ziemann,et al.  Microparticles: major transport vehicles for distinct microRNAs in circulation , 2012, Cardiovascular research.

[38]  Christian Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[39]  B. Lévy,et al.  Microparticles From Ischemic Muscle Promotes Postnatal Vasculogenesis , 2009, Circulation.